Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Chemomab Therapeutics Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 10 | 12 | +2 |
| Shares | 2.88M | 3.09M | +208.7K (+7.3%) |
| Value | $82.6M | $58.7M | −$23.9M (−28.9%) |
New holders (6)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 290,534 | $5.53M | 0.99% |
| Marshall Wace, LLP | 63,554 | $1.21M | 0.01% |
| Marshall Wace North America L.P. | 44,035 | $837.0K | 0.00% |
| Virtu Financial LLC | 13,180 | $251.0K | 0.02% |
| Spire Wealth Management | 500 | $10.0K | 0.00% |
| JPMorgan Chase & Co | 51 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Maven Securities LTD | 126,562 | $3.63M |
| CVI Holdings, LLC | 93,750 | $2.69M |
| Renaissance Technologies LLC | 7,023 | $202.0K |
| Tower Research Capital LLC (TRC) | 76 | $2.00K |